Back to top

Image: Bigstock

Citrix Unveils Solutions to Boost Workspace Productivity

Read MoreHide Full Article

Citrix Systems, Inc. CTXS recently introduced Citrix Analytics for Performance, with an aim to aid IT administrators to assess and address system performance concerns to boost employee efficiency.

The latest solution provides IT admin with clear picture of end-user’s experience with the functioning of the apps and access within Citrix Virtual Apps and Desktops.

This aids the admin to improve user experience, which in turn enhances employee engagement and improves productivity.

Moreover, the latest solution is compatible with on-premise and cloud-based Citrix Virtual Apps and Desktop installations, which is a major positive.

Real-time Visibility into Network Systems: A Key Catalyst

Notably, Citrix Virtual Apps and Desktops features real-time ML engine, which is integrated with Citrix Analytics for Performance. This facilitates IT admin to quantify users’ experience to get a user-specific “UX Score.”

UX Score takes into account machine performance, and application access parameters including network latency, user logon time, and network stability. IT admin can leverage this quantified score to evaluate and prepare a report on system performance and user experience.

Real-time visibility into network systems will aid IT admin to fix any problem concerning productivity and thereby, deliver engaging user experience.

Rise in enterprise spend on workspace productivity solutions from small and medium enterprises, is expected to bolster adoption of Citrix Analytics for Performance solution. This is anticipated to generate incremental revenues, which in turn will drive the top line in the days ahead.

Citrix Systems, Inc. Revenue (Quarterly)


Citrix Systems, Inc. Revenue (Quarterly)

Citrix Systems, Inc. revenue-quarterly | Citrix Systems, Inc. Quote

Focus on Enterprise Workspace Productivity Holds Promise

Citrix is leaving no stone unturned to capitalize on increasing popularity of enterprise workspace productivity solutions.

On the back of ongoing workspace trends of Bring Your Own Devices (BYOD) and increasing number of mobile workers, the company is anticipated to benefit from strength in its workspace productivity and desktop virtualization solutions.

In fact, the company is gaining from solid adoption of unified workspace solutions and hybrid cloud offerings. Furthermore, traction witnessed by ShareFile deserves a special mention.

Notably, in third-quarter 2019, Citrix’s Workspace revenues (accounting 70% of total revenues) improved 1% year over year to $513 million courtesy of higher adoption of SaaS-bases subscription solutions.

Per ResearchAndMarkets data, business productivity software market is projected to see a CAGR of 12.6% between 2019 and 2024. The growth projection reinforces Citrix’s efforts in this domain.

Additionally, acquisitions of Cedexis and Sapho remain noteworthy. The buyouts are expected to aid Citrix in enhancing Workspace suite with guided work capabilities and traffic management functionalities.

However, increasing investments on portfolio expansion, and product enhancements, are likely to weigh on margin expansion, at least in the near term.

Zacks Rank and Key Picks

Citrix carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader technology sector are Synopsys (SNPS - Free Report) , Keysight Technologies KEYS, and Garmin GRMN, each flaunting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings growth rate for Synopsys, Keysight and Garmin is currently pegged at 12.76%, 10% and 7.35%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Synopsys, Inc. (SNPS) - Free Report >>